scholarly journals Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain

2012 ◽  
Vol 39 (9) ◽  
pp. 1467-1477 ◽  
Author(s):  
Cindy Casteels ◽  
Michel Koole ◽  
Sofie Celen ◽  
Guy Bormans ◽  
Koen Van Laere
2013 ◽  
Vol 41 (2) ◽  
pp. 308-321 ◽  
Author(s):  
Cindy Casteels ◽  
Nathalie Gérard ◽  
Kris van Kuyck ◽  
Lies Pottel ◽  
Bart Nuttin ◽  
...  

2013 ◽  
Vol 3 (1) ◽  
pp. 59 ◽  
Author(s):  
Kimy M Emonds ◽  
Michel Koole ◽  
Cindy Casteels ◽  
Laura Van den Bergh ◽  
Guy M Bormans ◽  
...  

2010 ◽  
Vol 117 (2-3) ◽  
pp. 170 ◽  
Author(s):  
Jenny Ceccarini ◽  
Marc De Hert ◽  
Ruud van Winkel ◽  
Dagmar Koethe ◽  
Guy Bormans ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Giovanna Cacciola ◽  
Teresa Chioccarelli ◽  
Silvia Fasano ◽  
Riccardo Pierantoni ◽  
Gilda Cobellis

Spermatogenesis is a complex mechanism which allows the production of male gametes; it consists of mitotic, meiotic, and differentiation phases. Spermiogenesis is the terminal differentiation process during which haploid round spermatids undergo several biochemical and morphological changes, including extensive remodelling of chromatin and nuclear shape. Spermiogenesis is under control of endocrine, paracrine, and autocrine factors, like gonadotropins and testosterone. More recently, emerging pieces of evidence are suggesting that, among these factors, estrogens may have a role. To date, this is a matter of debate and concern because of the agonistic and antagonistic estrogenic effects that environmental chemicals may have on animal and human with damaging outcome on fertility. In this review, we summarize data which fuel this debate, with a particular attention to our recent results, obtained using type 1 cannabinoid receptor knockout male mice as animal model.


Neuroscience ◽  
2016 ◽  
Vol 323 ◽  
pp. 35-42 ◽  
Author(s):  
J.F. Oliveira da Cruz ◽  
L.M. Robin ◽  
F. Drago ◽  
G. Marsicano ◽  
M. Metna-Laurent

2012 ◽  
Vol 303 (4) ◽  
pp. E475-E487 ◽  
Author(s):  
Rosanna Chianese ◽  
Vincenza Ciaramella ◽  
Donatella Scarpa ◽  
Silvia Fasano ◽  
Riccardo Pierantoni ◽  
...  

Gonadotropin-releasing hormone (either GnRH1 or GnRH2) exerts a local activity in vertebrate testis, including human testis. Relationships between endocannabinoid (eCB) and GnRH systems in gonads have never been elucidated in any species so far. To reveal a cross-talk between eCBs and GnRH at testicular level, we characterized the expression of GnRH ( GnRH1 and GnRH2) as well as GnRH receptor ( GnRH-R1, -R2, and -R3) mRNA in the testis of the anuran amphibian Rana esculenta during the annual sexual cycle; furthermore, the corresponding transcripts were localized inside the testis by in situ hybridization. The possible endogenous production of the eCB, anandamide (AEA), was investigated in testis by analyzing the expression of its biosynthetic enzyme, Nape-pld. Incubations of testis pieces with AEA were carried out in the postreproductive period (June) and in February, when a new spermatogenetic wave takes place. In June, AEA treatment significantly decreased GnRH1 and GnRH-R2 mRNA, stimulated the transcription of GnRH2 and GnRH-R1, and did not affect GnRH-R3 expression. In February, AEA treatment upregulated GnRH2 and GnRH-R3 mRNA, downregulated GnRH-R2, and did not affect GnRH1 and GnRH-R1 expression. These effects were mediated by type 1 cannabinoid receptor ( CB1) since they were fully counteracted by SR141716A (Rimonabant), a selective CB1 antagonist. In conclusion, eCB system modulates GnRH activity in frog testis during the annual sexual cycle in a stage-dependent fashion.


Sign in / Sign up

Export Citation Format

Share Document